Vericiguat and NT-proBNP in patients with heart failure with reduced ejection fraction: analyses from the VICTORIA trial.

Senni, Michele; Lopez-Sendon, Jose; Cohen-Solal, Alain; Ponikowski, Piotr; Nkulikiyinka, Richard; Freitas, Cecilia; Vlajnic, Vanja Miodrag; Roessig, Lothar; Pieske, Burkert

Senni, Michele; Lopez-Sendon, Jose; Cohen-Solal, Alain; Ponikowski, Piotr; Nkulikiyinka, Richard; Freitas, Cecilia; Vlajnic, Vanja Miodrag; Roessig, Lothar; Pieske, Burkert.

Affiliation

Senni M; Cardiology Division, Cardiovascular Department, Ospedale Papa Giovanni XXIII, Bergamo, University of Milan-Bicocca, Milan, Italy.
Lopez-Sendon J; IdiPaz Research Institute, Hospital La Paz, Universidad Autonoma Madrid, Madrid, Spain.
Cohen-Solal A; UMR-S942 (MASCOT), Université Paris Cite, Lariboisiere Hospital, AP-HP, Paris, France.
Ponikowski P; Cardiology Department, Wroclaw Medical University, Wroclaw, Poland.
Nkulikiyinka R; Clinical Development, Bayer AG, Wuppertal, Germany.
Freitas C; Bayer AG, Berlin, Germany.
Vlajnic VM; Data Sciences & Analytics (DS&A), Bayer US LLC, Whippany, NJ, USA.
Roessig L; Clinical Development, Bayer AG, Wuppertal, Germany.
Pieske B; Department of Internal Medicine and Cardiology, Charité University Medicine, and German Heart Center, Berlin, Germany.

ESC Heart Fail ; 9(6): 3791-3803, 2022 12.

Article in En | MEDLINE | ID: mdl-35880474

Subject(s)
Key words

Heart failure; Heart failure with reduced ejection fraction; NT-proBNP

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Heart Failure Type of study: Clinical_trials / Guideline / Prognostic_studies / Systematic_reviews Limits: Humans Language: En Journal: ESC Heart Fail Year: 2022 Document type: Article Affiliation country: Italia Country of publication: Reino Unido

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google